≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Tooth agenesis EXCLUDE clefts and syndromes

Endpoint Browser PheWeb

K11_HYPO_ONLY

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

  • not K11_CLEFT_SYNDR
518942

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Primary healthcare outpatient: ICD-10 — K00.00
  • Hospital discharge: ICD-10 — K00.00
  • Hospital discharge: ICD-9 — 5200A
  • Hospital discharge: ICD-8 — 52000
  • Cause of death: ICD-10 — K00.00
  • Cause of death: ICD-9 — 5200A
  • Cause of death: ICD-8 — 52000

3 out of 7 registries used, show all original rules.

1568

4. Check minimum number of events

None

1568

5. Include endpoints

None

1568

6. Filter based on genotype QC (FinnGen only)

1568

Control definitions (FinnGen only)

Control conditions
not K11_CLEFT_SYNDR

Extra metadata

First used in FinnGen datafreeze
DF10

Similar endpoints

↥

List of similar endpoints to Tooth agenesis EXCLUDE clefts and syndromes based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Similar with more cases:

None

Venn diagram with a set fully inside an highlighted set Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 37565 21955 15575
Only index persons 32984 19326 13658
Unadjusted period prevalence (%)
Whole population 0.55 0.63 0.44
Only index persons 0.63 0.71 0.52
Median age at first event (years)
Whole population 12.21 12.26 12.09
Only index persons 12.85 12.96 12.68

-FinnGen-

Key figures

All Female Male
Number of individuals 1568 1150 418
Unadjusted period prevalence (%) 0.34 0.39 0.18
Median age at first event (years) 20.14 19.93 20.73

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
1388
Matched controls
13879
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
EBB10
NOMESCO Finland
Insertion of dental implant
234.3
323.0
351
20
K00.00
ICD-10 Finland
Hypodontia
+∞
323.0
1374
*
SBB10
NOMESCO Finland
Teeth copy
6.9
216.5
695
1752
SPC20
NOMESCO Finland
Attachment of crone of tooth to implant
182.4
210.5
216
14
EBB15
NOMESCO Finland
Insertion of dental implant abutment
158.7
207.1
215
16
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
13.2
160.0
297
280
SJD00
NOMESCO Finland
Removal or reattacment of arrow in fixed orthodontisk device
6.7
149.5
439
894
SBB00
NOMESCO Finland
Fotograf of mouth and teeth
7.8
149.1
386
656
EBB11
NOMESCO Finland
Insertion of additional dental implant in one session
154.9
145.5
152
11
SJD10
NOMESCO Finland
Attachment of arrow to fixed orthodontisk device
5.9
129.8
419
941
SAA04
NOMESCO Finland
Special inverstigation of mouth
5.7
115.4
380
859
SJD20
NOMESCO Finland
Attachment of modifiable arrow of fixed orthodontisk device
6.5
114.1
332
641
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
10.7
112.3
229
251
ECB40
NOMESCO Finland
Surgical treatment of fracture of alveolus
116.0
108.9
117
11
SPA00
NOMESCO Finland
Changing form of teeth in prepation for prothetic work
18.7
103.5
163
98
SJC50
NOMESCO Finland
Removal of orthodontisk device with at least 7 brackets
5.2
93.9
329
778
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
3.3
93.9
894
4952
SJD40
NOMESCO Finland
Fixation of ready made palatinal or lingual arrow
5.0
93.7
345
862
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
4.9
91.8
343
868
EB1MA
NOMESCO Finland
Cephalometry with X-ray
5.0
86.4
315
772
SJB00
NOMESCO Finland
Fitting of loose orthodontic device with user information
4.5
85.4
351
972
SAA03
NOMESCO Finland
Extended examination of mouth
3.2
84.9
985
6055
SJX10
NOMESCO Finland
Short check-up visit for orthodontisk therapy
3.7
77.4
415
1440
SJC03
NOMESCO Finland
Positioning and fixed attachment of brackets, extensive
5.2
76.4
263
598
SJC10
NOMESCO Finland
Orthodontic bandage in one tooth
4.9
76.4
279
677
SJC01
NOMESCO Finland
Positioning and fixed attachment of single bracket (Bracket with fixed attachment)
4.4
71.6
294
799
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.8
69.4
695
3676
SXC05
NOMESCO Finland
Other oral or dental procedure
3.6
67.0
355
1202
K07.23
ICD-10 Finland
Deep bite
4.5
65.3
261
686
K00.09
ICD-10 Finland
Lack of teeth due to lack of dental development UNS
37.8
64.3
82
23
SJD30
NOMESCO Finland
Demanding attachment of arrow to fixed orthodontisk device
5.3
64.3
214
463
SPA20
NOMESCO Finland
Selection and insertion of implantdistans
100.5
61.4
67
7
K07.13
ICD-10 Finland
Retrognaty, mandibular
7.4
60.0
150
223
Z96.5
ICD-10 Finland
Presence of tooth-root and mandibular implants
118.8
53.2
57
5
SXB00
NOMESCO Finland
Removeal of sutres from oral mucosa
4.7
51.3
187
441
SJC02
NOMESCO Finland
Positioning and fixed attachment of brackets
4.5
51.2
198
496
SPF40
NOMESCO Finland
Removal and reattachment with cement of tooth crone or short bridge
24.1
48.4
69
30
EB1AI
NOMESCO Finland
Cone beam imaging of teeth and jaws (one quarter)
11.7
46.6
88
80
SJX11
NOMESCO Finland
Therapeutic intervention or check-up related to orthodontic treatment, restricted
3.0
45.8
310
1215
SHB00
NOMESCO Finland
Prepation and fitting of bite rail to mouth
3.1
44.6
276
1017
SPA05
NOMESCO Finland
Guiding rail
232.3
44.2
45
*
SJX21
NOMESCO Finland
Therapeutic intervention or check-up related to orthodontic treatment
3.3
43.5
246
848
SPA41
NOMESCO Finland
Precision impression for fixed dental prosthesis
27.9
43.2
59
22
SJC40
NOMESCO Finland
Removal of orthodontisk device with at most 6 brackets
3.3
43.0
241
823
SAC02
NOMESCO Finland
Separate planning of oral and dental treatment, demanding
4.0
42.6
183
503
EDC10
NOMESCO Finland
Sagittal osteotomy of ramus of mandible
21.6
42.1
62
30
SPC10
NOMESCO Finland
Attachment of standard crone of tooth
17.6
40.5
64
38
SPC40
NOMESCO Finland
Preparation of first or second intermediate attachment tooth for bridge
77.6
40.1
45
6
SPC08
NOMESCO Finland
Implant crown
102.9
36.9
40
*
EBA00
NOMESCO Finland
Extraction of tooth
2.1
35.9
638
4031
EMAK
NOMESCO Finland
NA
5.3
35.8
115
234
EB1BI
NOMESCO Finland
Cone beam imaging of teeth and jaws (1–2 quarters)
9.7
35.8
74
80
SJX20
NOMESCO Finland
Check-up visit for orthodontisk therapy
3.0
35.6
227
843
WZA90
NOMESCO Finland
Other doctors statement
2.2
34.9
506
2920
SJB60
NOMESCO Finland
External device grinding and adaptation
3.4
34.7
184
599
SHA02
NOMESCO Finland
Correction of physiology of bite - basic therapy visit
3.3
34.5
191
641
SXC03
NOMESCO Finland
Other oral or dental procedure
18.3
34.2
53
30
K07.14
ICD-10 Finland
Retrognaty, maxillary
10.8
33.9
66
64
SBB20
NOMESCO Finland
Tooth X-ray examination in conjunction with visit to dentist
13.4
33.1
58
45
K08.2
ICD-10 Finland
Atrophy of edentulous alveolar ridge
30.2
33.1
44
15
SPC30
NOMESCO Finland
Tooth bridge attacment with resins
174.1
32.8
34
*
SAC03
NOMESCO Finland
Separate planning of oral and dental treatment, very demanding
8.5
32.3
72
89
SJC00
NOMESCO Finland
Bracket with fixed attachment
19.8
31.9
48
25
EEC05
NOMESCO Finland
Le Fort I osteotomy
32.4
31.4
41
13
SAC01
NOMESCO Finland
Separate planning of oral and dental treatment, standard
3.1
31.1
190
682
POLI
NOMESCO Finland
NA
319.7
30.9
31
*
OIKK
NOMESCO Finland
NA
2.6
30.6
254
1103
K07.25
ICD-10 Finland
Anomalies of dental arch relationship
3.6
30.3
147
444
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.9
30.0
775
5512
SPA02
NOMESCO Finland
Preparation for dental prosthetics
13.5
29.8
52
40
ZXX02
NOMESCO Finland
Extent of procedure, 2 units
9.9
28.6
58
61
SPB10
NOMESCO Finland
Production of temporary crone to tooth
25.0
28.0
39
16
EB1AD
NOMESCO Finland
Cone beam CT of teeth and jaws (one quarter)
22.8
27.9
40
18
SPA40
NOMESCO Finland
Precision impression for dental prosthesis
30.7
27.3
36
12
SAA01
NOMESCO Finland
Simple examination of mouth
2.1
27.0
1118
9266
T84.60
ICD-10 Finland
Gingivitis associated with dental implants
52.8
26.3
31
6
K07.24
ICD-10 Finland
Open bite
5.0
25.8
85
178
SHA03
NOMESCO Finland
Correction of physiology of bite - demanding therapy visit
4.7
25.5
90
203
EB1WA
NOMESCO Finland
NA
16.4
25.0
40
25
K00.01
ICD-10 Finland
Anodontia
254.5
24.7
25
*
SPB20
NOMESCO Finland
Temporary bridge between two or more teeth
43.7
24.6
30
7
SAA02
NOMESCO Finland
Basic examination of mouth
2.1
23.7
1175
10074
SAALT
NOMESCO Finland
NA
4.0
23.7
98
258
K01.0
ICD-10 Finland
Embedded teeth
4.0
22.9
96
256
EB1CI
NOMESCO Finland
Cone beam imaging of teeth and jaws (3-4 quarters)
16.8
22.8
36
22
SPF00
NOMESCO Finland
Repatation of teeth prosthesis
13.0
21.7
38
30
K07.60
ICD-10 Finland
Snapping jaw
3.1
20.5
118
404
SPA60
NOMESCO Finland
Fitting of intermediary dental prosthesis structures, 1 to 3 units
17.6
20.1
31
18
SXC02
NOMESCO Finland
Other oral or dental procedure, restricted
4.8
19.7
67
146
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
3.1
18.9
108
368
EFB40
NOMESCO Finland
Removal of internal or external fixation device from facial bones
19.0
18.7
28
15
OIKH
NOMESCO Finland
NA
2.4
18.6
165
730
K07.33
ICD-10 Finland
Crowding of tooth or teeth
11.6
18.5
34
30
ECB20
NOMESCO Finland
Oral alveoplasty
22.0
18.2
26
12
EEC45
NOMESCO Finland
Reconstruction of maxilla using bone graft
182.2
17.5
18
*
SJA02
NOMESCO Finland
Plan for orthodontic care
17.2
17.4
27
16
SPC01
NOMESCO Finland
Fixed dental crown
11.7
17.1
31
27
K07.11
ICD-10 Finland
Retrognathism (mandibular)(maxillary)
8.4
17.0
37
45
SPF50
NOMESCO Finland
Removal and reattachment with cement of tooth bridnge
50.7
17.0
20
*
EB1BD
NOMESCO Finland
Extensive cone beam CT of teeth and jaws (two quarters)
64.1
16.8
19
*
K07.30
ICD-10 Finland
Spacing, abnormal of tooth or teeth
2.2
16.4
184
909
WX110
NOMESCO Finland
Local anesthesy
1.7
16.2
1018
8636
EB1BA
NOMESCO Finland
Extensive intraoral X-ray examination
18.8
16.0
24
13
SPC09
NOMESCO Finland
Implant crown, demanding
86.1
15.6
17
*
T84.62
ICD-10 Finland
Osteitis associated with dental implants
23.7
15.1
21
9
ECA55
NOMESCO Finland
Complicated parodontal operation
20.3
15.1
22
11
SPA30
NOMESCO Finland
Grinding of a single crown and bridge pillar or a single post and crown
11.9
15.1
27
23
SJX00
NOMESCO Finland
Reparation of orthodontiskt device by dentist
4.9
15.1
49
103
Z01.6
ICD-10 Finland
Radiological examination, not elsewhere classified
2.2
14.7
159
773
SPF20
NOMESCO Finland
Temporary soling for filling
21.3
14.7
21
10
K00.0
ICD-10 Finland
Anodontia
+∞
14.6
14
*
SJA01
NOMESCO Finland
Estimation of need for orthodontic care
10.2
14.5
28
28
K07.10
ICD-10 Finland
Asymmetry of jaw
9.5
14.5
29
31
ECB10
NOMESCO Finland
Reconstruction of gingiva
36.4
14.5
18
5
SJB10
NOMESCO Finland
Fitting of loose orthodontic device with user information, demanding
2.9
14.4
87
308
SPA01
NOMESCO Finland
Pre-prosthetic dental procedures
30.4
13.9
18
6
ECU00
NOMESCO Finland
Removal of implant or external fixation device from alveoli
53.9
13.8
16
*
SPB30
NOMESCO Finland
Temporary partial teeth prothesis
53.9
13.8
16
*
SJA04
NOMESCO Finland
Very demanding plan for orthodontic care
14.9
13.6
22
15
SPC25
NOMESCO Finland
Other demanding attachment of crone of tooth
21.4
13.3
19
9
SHA04
NOMESCO Finland
Correction of physiology of bite - very demanding therapy visit
5.8
13.0
36
63
EB1JA
NOMESCO Finland
Double panorama tomography of teeth and jaws or similar X-ray examination
8.9
13.0
27
31
ZXX04
NOMESCO Finland
Extent of procedure, 4 units
13.1
12.9
22
17
ECA70
NOMESCO Finland
Regenerative parodontal operation or gingiva and alveolus transplantation
22.8
12.9
18
8
SDA02
NOMESCO Finland
Parodonthologic therapy
1.6
12.8
490
3590
SJA03
NOMESCO Finland
Demanding plan for orthodontic care
14.2
12.8
21
15
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.5
12.8
675
5328
K07.20
ICD-10 Finland
Crossbite (anterior)(posterior)
2.9
12.6
78
281
SDA03
NOMESCO Finland
Demanding parodonthologic therapy
1.6
12.0
428
3070
EBA10
NOMESCO Finland
Surgical removal of tooth
1.7
11.9
270
1714
SPF41
NOMESCO Finland
Repair of dental crown, bridge or implant structure, standard
11.8
11.8
21
18
K03.64
ICD-10 Finland
Dental calculus supragingival
1.5
11.7
498
3721
SJF01
NOMESCO Finland
Assessment of need for orthodontic treatment
2.0
11.4
156
835
Z3229
NOMESCO Finland
Other healthcare associate professional
2.2
11.2
119
574
SFB30
NOMESCO Finland
Filling of tree or more surfaces of tooth reproduced outside mouth
20.2
11.1
16
8
SPA10
NOMESCO Finland
Setting attachments on tooth or implanted bracket or imblant based structures
43.7
10.9
13
*
ECA00
NOMESCO Finland
Surgical exposure of tooth
4.6
10.9
37
83
OIKAL
NOMESCO Finland
NA
2.6
10.8
82
333
SBA00
NOMESCO Finland
Microbiological examinations
4.0
10.8
42
107
SPE90
NOMESCO Finland
Other fitting and preparation of partial tooth prosthesis
7.6
10.7
24
32
EBB20
NOMESCO Finland
Transplantation of tooth
60.5
10.6
12
*
OIKKK
NOMESCO Finland
NA
6.1
10.6
28
47
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.5
10.5
413
3012
K00.21
ICD-10 Finland
Macrodontia
110.8
10.4
11
*
K07.00
ICD-10 Finland
Macrognatia (hyperplasia) of the upper jaw
32.8
10.3
13
*
AA3AI
NOMESCO Finland
Cone beam CT of facial bones
6.5
10.0
25
39
ECW06
NOMESCO Finland
Insertion of mini-implant or miniscrew
40.4
10.0
12
*
EAB10
NOMESCO Finland
Excision and repair of frenum of lip
8.2
9.8
21
26
YNA09
NOMESCO Finland
Other excision of bone for transplantation
55.4
9.7
11
*
Z01.2
ICD-10 Finland
Dental examination
1.4
9.6
697
5737
SHA01
NOMESCO Finland
Correction of physiology of bite - simple therapy visit
1.8
9.5
163
946
K07.26
ICD-10 Finland
Anomalies of dental arch relationship
7.6
9.4
21
28
SPB15
NOMESCO Finland
Temporary dental implant crown
100.7
9.4
10
*
ZZH22
NOMESCO Finland
Graft of patients own bone, block
17.7
9.4
14
8
52000
ICD-8 Finland
Disorder of tooth development and eruption, Anodontia
+∞
9.4
9
*
ECW05
NOMESCO Finland
Restricted insertion of mini-implant or miniscrew
+∞
9.4
9
*
TEW99
NOMESCO Finland
Other minor procedure in surgery of teeth, jaws, mouth and pharynx
2.5
9.3
70
286
SPC35
NOMESCO Finland
Production and attachment of single tooth bridge
7.3
9.2
21
29
ZXX03
NOMESCO Finland
Extent of procedure, 3 units
7.8
9.1
20
26
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
2.9
9.1
55
198
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
1.7
9.1
188
1159
OIKRE
NOMESCO Finland
NA
3.5
9.0
41
121
ZXA10
NOMESCO Finland
Bilateral
1.7
9.0
190
1178
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.4
9.0
798
6786
SPA45
NOMESCO Finland
Precision impression for dental prosthesis, demanding
24.2
8.9
12
5
K07.18
ICD-10 Finland
Another anomaly in the relationship between jaw and skull base
12.6
8.9
15
12
-1
NOMESCO Finland
NA
1.4
8.7
672
5557
EFB60
NOMESCO Finland
Osteoplasty of jaws or facial bones with use of osseous graft or foreign material
+∞
8.3
8
*
K01.14
ICD-10 Finland
Retained premolar with obstruction in the upper jaw
14.6
8.2
13
9
K05.30
ICD-10 Finland
Periodontitis complex
2.1
8.1
88
430
SJD50
NOMESCO Finland
Production and attachment of palatinal or lingual arrow
2.7
8.0
52
197
K07.1
ICD-10 Finland
Anomalies of jaw-cranial base relationship
13.1
7.9
13
10
Z94.0
ICD-10 Finland
Kidney transplant status
5.2
7.9
23
45
WYA10
NOMESCO Finland
First aid or other corresponding healthcare contact
1.8
7.8
131
754
SPC31
NOMESCO Finland
Surface-retained dental bridge, reproduced outside mouth
45.2
7.7
9
*
Z85.8
ICD-10 Finland
Personal history of malignant neoplasms of other organs and systems
45.2
7.7
9
*
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
1.8
7.7
125
713
K03.5
ICD-10 Finland
Ankylosis of teeth
25.1
7.6
10
*
SPF30
NOMESCO Finland
Soling for prothesis
8.9
7.5
15
17
SDA04
NOMESCO Finland
Very demanding parodonthologic therapy
1.5
7.5
247
1714
SPF42
NOMESCO Finland
Repair of dental crown, bridge or implant structure, demanding
80.5
7.4
8
*
SJE90
NOMESCO Finland
Finishing face of orthodontick therapy
4.1
7.4
27
67
K01.12
ICD-10 Finland
Retained canine with obstruction in the upper jaw
4.2
7.3
26
63
K00.9
ICD-10 Finland
Disorder of tooth development, unspecified
+∞
7.3
7
*
EBW99
NOMESCO Finland
Other operation on tooth
15.8
7.2
11
7
SPC06
NOMESCO Finland
Fixed dental bridge pontic or bridge or crown lug
30.2
7.2
9
*
SPF10
NOMESCO Finland
Demanding repatation of teeth prosthesis
8.0
7.1
15
19
SPB06
NOMESCO Finland
Production of temporary clinic-made tooth- or implant-retained crown or bridge unit
12.1
7.1
12
10
TJA35
NOMESCO Finland
Removal of peritoneal dialysis catheter
10.1
7.0
13
13
SDE02
NOMESCO Finland
Periodontal treatment by dental hygienist
1.4
6.8
308
2284
ZXE20
NOMESCO Finland
More than three and less than five hours
1.8
6.8
119
694
OIKVA
NOMESCO Finland
NA
2.0
6.8
89
470
SPA61
NOMESCO Finland
Fitting of intermediary dental prosthesis structures, 4 to 6 units
16.8
6.7
10
6
K07.19
ICD-10 Finland
Anomalies in the relationship between jaw and skull base UNS
16.8
6.7
10
6
K06.00
ICD-10 Finland
Local gingivore traction
4.3
6.7
23
54
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
4.2
6.6
23
55
WX002
NOMESCO Finland
Sedation and analgesia
1.6
6.5
154
984
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
2.3
6.5
55
241
137
Kela drug reimbursment
Uraemia requiring dialysis
6.2
6.5
16
26
D19
ICPC
Teeth/gum symptom/complaint
1.4
6.5
390
3049
SPC45
NOMESCO Finland
Preparation of third or later intermediate attachment tooth for bridge
70.2
6.4
7
*
ECA50
NOMESCO Finland
Parodontal operation
7.4
6.4
14
19
SCD01
NOMESCO Finland
Simple removal of tooth plaque or tartar
2.9
6.4
37
131
Z99.2
ICD-10 Finland
Dependence on renal dialysis
11.1
6.3
11
10
J01CE02
ATC
phenoxymethylpenicillin; oral
1.3
6.3
912
8158
5200A
ICD-9 Finland
Disorders of tooth development and eruption, Anodontia
+∞
6.3
6
*
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.4
6.1
368
2872
XX7LW
NOMESCO Finland
NA
12.6
6.1
10
8

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
18
38
4.78
8.12
8.3
7.6
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
55
266
2.11
6.15
8.7
6.7
iu/ml
167.9
397.1
—
9
29
(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
12
24
5.03
5.74
6.6
6.8
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
147
992
1.53
5.33
6.7
4.7
%
1.5
1.5
0.01
135
909
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
12
27
4.47
5.03
5.0
6.3
—
—
—
0
0
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
12
27
4.47
5.03
4.8
6.2
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
14
36
3.91
4.99
4.1
6.2
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
359
2875
1.32
4.90
5.2
4.8
inr
1.1
1.1
0.02
115
1005
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
608
5231
1.26
4.73
4.2
4.0
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
10
21
4.78
4.53
1.5
3.1
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
207
1544
1.39
4.47
3.5
2.3
umol/l
15.2
14.6
0.46
193
1444
(3021440) Promyelocytes/100 leukocytes in Blood
124
840
1.52
4.44
5.2
4.5
%
0.1
0.1
0.05
27
206
(3023520) Reticulocytes [#/volume] in Blood
104
685
1.55
4.24
5.7
3.7
e9/l
64.9
68.4
0.41
74
480
(3025159) Blasts/100 leukocytes in Blood
119
808
1.51
4.23
5.3
4.5
%
0.1
0.1
0.13
25
178
(3002179) Metamyelocytes/100 leukocytes in Blood
118
816
1.48
3.86
4.9
4.2
%
0.5
0.5
0.09
22
165
(3018010) Neutrophils/100 leukocytes in Blood
706
6278
1.23
3.83
7.4
6.2
%
54.9
54.6
0.26
662
5952
(3017181) Myelocytes/100 leukocytes in Blood
125
876
1.46
3.82
5.1
4.4
%
0.8
0.8
0.02
28
224
(3002030) Lymphocytes/100 leukocytes in Blood
715
6370
1.22
3.80
7.6
6.4
%
31.2
31.3
0.13
665
6017
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
168
1250
1.38
3.69
3.7
2.4
%
25.1
23.5
0.65
145
1102
(42870588) Differential panel, method unspecified - Blood
489
4198
1.24
3.68
7.6
6.6
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
183
1383
1.37
3.66
3.6
2.3
g/l
2.5
2.5
0.02
169
1281
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
52
298
1.77
3.66
1.8
2.4
g/l
1.1
1.3
1.05
45
271
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
851
7770
1.21
3.37
7.3
6.0
u/l
81.0
80.2
0.19
794
7295
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
51
300
1.72
3.31
1.5
1.4
u/l
17.6
14.4
0.36
46
261
(3023323) Follitropin [Units/volume] in Serum or Plasma
141
1039
1.39
3.30
1.8
1.6
iu/l
16.7
15.8
0.16
118
838
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
62
388
1.62
3.20
1.9
1.6
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
36
193
1.88
3.16
1.7
1.8
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
73
479
1.55
3.10
5.3
4.5
g/l
3.1
3.3
0.28
67
461
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
1075
10083
1.21
3.04
4.1
3.8
pmol/l
14.2
14.3
0.81
966
9208
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
59
371
1.61
3.01
2.0
1.6
u/ml
101.7
95.1
—
9
56
(3019069) Monocytes/100 leukocytes in Blood
676
6086
1.19
2.99
8.0
6.7
%
8.1
8.0
0.46
629
5755
(3006504) Eosinophils/100 leukocytes in Blood
671
6039
1.19
2.98
7.9
6.5
%
2.9
2.8
0.50
623
5685
(3036481) Cortisol [Moles/volume] in Serum or Plasma
161
1236
1.34
2.93
2.5
2.1
nmol/l
345.2
384.3
1.89
152
1159
(3030905) Polymorphonuclear cells [#/volume] in Blood
43
251
1.73
2.90
3.0
3.7
e9/l
3.5
3.9
0.67
43
251
(3013826) Glucose [Moles/volume] in Serum or Plasma
660
5942
1.19
2.89
5.6
4.4
mmol/l
6.1
6.2
0.11
585
5350
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
65
424
1.56
2.86
1.6
1.7
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
43
254
1.71
2.79
3.2
3.9
%
49.1
54.9
2.08
43
254
(3019198) Lymphocytes [#/volume] in Blood
728
6625
1.18
2.79
7.6
6.4
e9/l
2.0
2.0
1.10
663
5927
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
531
4704
1.19
2.76
6.0
5.4
umol/l
10.6
10.3
0.22
498
4363
(3024561) Albumin [Mass/volume] in Serum or Plasma
430
3736
1.21
2.76
6.7
5.1
g/l
37.2
37.6
1.08
403
3488
(3022096) Basophils/100 leukocytes in Blood
646
5823
1.19
2.76
8.1
6.6
%
0.7
0.7
0.23
597
5487
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
29
152
1.92
2.76
5.6
4.0
%
93.3
93.4
0.01
29
147
(3018677) aPTT in Platelet poor plasma by Coagulation assay
173
1356
1.31
2.74
4.4
3.1
s
29.3
29.8
0.58
168
1324
(3013707) Erythrocyte sedimentation rate by Westergren method
904
8395
1.18
2.67
4.3
3.7
mm/h
8.2
8.1
0.10
860
7788
(3042733) HLA Ab [Presence] in Serum
12
43
2.80
2.64
4.5
3.1
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1205
11482
1.21
2.64
4.7
4.3
mu/l
1.8
1.9
0.66
1135
10849
(3009214) Lutropin [Units/volume] in Serum or Plasma
114
845
1.38
2.62
2.0
1.7
u/l
6.6
7.9
1.15
92
672
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
54
347
1.58
2.56
18.4
11.5
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
10
33
3.04
2.52
1.4
2.1
u/l
212.7
187.6
—
10
33
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
38
224
1.71
2.51
1.4
1.3
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
112
836
1.37
2.48
2.0
2.1
nmol/l
10.0
10.6
0.26
94
743
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
515
4589
1.18
2.46
9.6
6.5
mmol/l
1.2
1.2
0.12
438
3970
(3041806) Other cells [#/volume] in Blood by Manual count
31
174
1.80
2.42
1.2
1.6
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
61
410
1.51
2.39
4.2
3.0
ng/l
156.2
131.5
0.12
53
359
(3022145) Colonoscopy Study observation
129
993
1.33
2.35
1.4
1.4
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
397
3478
1.19
2.29
3.6
2.6
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
78
1064
0.72
2.16
1.6
1.5
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
714
6585
1.15
2.11
8.1
6.8
e9/l
0.2
0.2
0.26
645
5855
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
342
2977
1.19
2.11
3.1
2.4
u/l
54.5
57.1
0.84
318
2752
(3004119) Hemoglobin [Mass/volume] in Venous blood
62
431
1.46
2.09
4.6
4.9
g/l
131.3
131.6
0.05
57
417
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
8
25
3.21
2.09
2.0
1.9
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
82
600
1.39
2.09
1.7
1.7
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
633
5796
1.15
2.06
10.0
8.4
e9/l
0.0
0.0
0.52
537
4683
(3019060) Gas panel - Arterial blood
47
310
1.53
2.04
3.2
5.7
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
690
6362
1.15
2.03
7.8
6.5
e9/l
0.5
0.5
0.11
607
5561
(3016244) Insulin [Units/volume] in Serum or Plasma
38
240
1.60
1.99
3.1
3.3
mu/l
24.7
28.1
0.18
38
222
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
13
57
2.29
1.97
1.4
1.2
—
—
—
0
0
(3036489) Thrombin time
75
547
1.39
1.96
4.3
3.7
s
21.4
21.4
0.02
66
483
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
527
4779
1.15
1.93
3.1
2.5
nmol/l
72.2
69.5
1.46
492
4480
(3006315) Basophils [#/volume] in Blood
689
6375
1.14
1.88
7.8
6.5
e9/l
0.0
0.0
0.35
606
5570
(40758292) HTLV I+II Ab panel - Serum
8
28
2.87
1.86
1.0
1.3
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
58
409
1.43
1.85
5.5
2.5
e6/l
0.2
0.2
0.03
58
393
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
31
190
1.64
1.84
1.5
1.3
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
13
59
2.21
1.84
1.2
1.3
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
1207
11617
1.17
1.84
12.0
9.3
mmol/l
3.9
3.9
0.47
1161
11195
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
83
624
1.35
1.82
4.4
3.8
mmol/l
1.2
1.2
0.04
71
534
(40768446) Kidney Pathology biopsy report
14
66
2.13
1.82
2.7
1.8
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
114
898
1.29
1.81
1.6
1.7
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
57
791
0.71
1.79
1.6
1.5
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
226
1925
1.20
1.78
3.7
2.6
umol/l
1704.0
4397.8
0.98
210
1741
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
9
36
2.51
1.74
2.8
2.3
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
9
36
2.51
1.74
2.8
2.3
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
12
54
2.23
1.74
1.4
1.2
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
765
7156
1.13
1.72
9.8
8.5
e9/l
3.9
3.8
0.20
675
6203
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
337
2980
1.17
1.72
2.5
2.5
mg/l
2.5
2.7
1.45
292
2585
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1307
12679
1.18
1.72
11.6
9.5
mg/l
19.6
19.9
0.14
989
9213
(4010399)
82
622
1.34
1.71
1.3
1.4
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
33
210
1.58
1.71
3.0
2.6
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
28
171
1.65
1.71
2.3
1.9
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
115
916
1.28
1.69
1.7
1.8
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
85
650
1.32
1.69
13.9
9.1
mmol/l
0.9
0.5
0.44
62
502
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
68
503
1.37
1.67
1.8
1.5
u/ml
259.1
196.0
0.81
35
265
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
109
866
1.28
1.64
5.5
4.5
u/l
238.6
232.7
0.15
102
829
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
11
49
2.25
1.63
2.2
3.2
u/ml
24.5
62.3
0.66
11
49
(3037467) Urinalysis macro (dipstick) panel - Urine
870
8223
1.13
1.62
4.8
3.8
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
163
1359
1.22
1.61
1.9
1.8
—
—
—
0
0
(4034850)
16
288
0.55
1.60
5.4
7.6
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
474
4317
1.14
1.60
1.6
1.5
u/ml
2.1
1.7
0.30
121
1050
(3028679) Herpes simplex virus Ab [Presence] in Serum
19
106
1.80
1.59
1.3
1.2
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
69
517
1.35
1.58
1.7
1.4
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
740
6933
1.13
1.58
3.9
2.9
ug/l
66.1
65.5
0.03
699
6541
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
494
4514
1.14
1.58
3.7
2.9
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
11
50
2.21
1.57
2.5
2.0
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
11
50
2.21
1.57
2.5
2.0
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
11
50
2.21
1.57
2.5
2.0
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
11
50
2.21
1.57
2.5
2.0
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
25
152
1.65
1.56
3.3
3.5
e9/l
1.2
1.3
0.07
12
92
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
23
137
1.69
1.55
1.8
1.4
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
167
1402
1.21
1.55
9.1
5.2
mmol/l
0.8
0.8
0.89
159
1333
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
916
8700
1.13
1.54
3.7
3.7
mmol/mol
36.5
37.0
1.22
864
8223
(3019550) Sodium [Moles/volume] in Serum or Plasma
1201
11605
1.15
1.53
11.9
9.2
mmol/l
139.4
139.5
1.46
1154
11229
(3005033) Fetal Nuchal fold Thickness US
57
768
0.73
1.53
1.5
1.5
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
30
193
1.56
1.51
1.3
1.2
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
6
21
2.86
1.50
1.5
9.3
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
193
1648
1.19
1.50
1.3
1.3
—
—
—
0
0
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
15
79
1.91
1.49
1.1
1.0
u/ml
22.9
17.5
—
6
18
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
169
1428
1.21
1.47
3.2
2.9
ng/l
337.5
592.7
0.77
85
732
(3017143) Hepatitis C virus Ab [Presence] in Serum
269
2368
1.16
1.46
1.8
1.6
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
343
3075
1.15
1.45
3.8
3.1
estimate
0.0
0.0
1.08
143
1188
(3047352) Trisomy 18 risk [Likelihood] in Fetus
58
771
0.74
1.44
1.4
1.5
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
119
973
1.24
1.43
3.7
3.5
g/l
0.2
0.2
0.07
110
917
(3037522) Nuclear Ab [Titer] in Serum
206
1778
1.18
1.43
1.4
1.4
titre
673.9
529.3
0.37
33
331
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
30
197
1.53
1.40
1.3
1.3
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
9
40
2.26
1.40
2.8
2.2
—
—
—
0
0
(3000012) Reticulocyte production index
9
40
2.26
1.40
1.1
1.1
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
98
788
1.26
1.37
1.7
2.1
e9/l
3.9
4.1
0.49
82
682
(4027681)
5
120
0.41
1.37
1.4
1.3
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
340
3059
1.14
1.37
5.1
4.3
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
14
75
1.87
1.34
1.4
1.1
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
141
1184
1.21
1.33
5.1
3.6
umol/l
9.0
6.1
0.65
126
985
(3008401) Mugwort IgE Ab [Units/volume] in Serum
74
577
1.30
1.33
1.1
1.1
u/ml
0.9
1.3
0.52
31
301
(3019150) Specific gravity of Urine by Refractometry
298
2666
1.14
1.30
3.1
2.9
kg/l
1.0
1.0
0.38
41
383
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
96
776
1.25
1.30
2.3
2.5
—
—
—
0
0
(3002256) Pathology report gross observation
135
1132
1.21
1.30
1.1
1.2
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
21
129
1.64
1.30
2.9
3.5
%
11.1
9.5
0.28
13
98
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
25
161
1.56
1.29
7.0
4.1
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
628
5883
1.11
1.27
3.7
2.9
estimate
0.0
0.0
0.50
142
1177
(3023368) Bacteria identified in Blood by Culture
229
2015
1.16
1.26
4.6
3.8
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
14
77
1.82
1.25
1.7
1.5
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
427
3920
1.12
1.24
1.8
1.8
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
20
123
1.63
1.24
2.6
4.1
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
442
4067
1.12
1.24
2.0
2.0
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
25
163
1.54
1.23
1.1
1.1
iu/ml
3.3
7.1
—
6
36
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
18
108
1.67
1.22
2.3
1.8
—
—
—
0
0
(3024932) HLA-DR beta [Type]
10
49
2.05
1.22
1.1
1.1
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
5
19
2.64
1.21
3.8
5.4
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
1184
11487
1.12
1.21
14.5
11.8
%
13.2
13.2
0.07
1155
11235
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
48
357
1.35
1.21
2.0
2.2
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
490
4541
1.11
1.20
1.7
1.7
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
256
2280
1.15
1.20
2.6
2.9
ug/g
98.0
104.2
0.13
202
1751
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
62
480
1.30
1.20
1.6
1.5
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
53
402
1.33
1.18
1.4
1.6
nmol/l
0.4
0.3
0.23
41
338
(3003458) Phosphate [Moles/volume] in Serum or Plasma
164
1414
1.18
1.18
13.8
7.1
mmol/l
1.2
1.2
0.51
156
1350
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
36
256
1.42
1.18
2.0
1.7
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
78
967
0.80
1.18
1.4
1.4
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
53
403
1.33
1.16
1.1
1.1
u/ml
8.4
7.8
0.06
21
196
(3024471) HLA-A [Type]
10
50
2.01
1.16
1.0
1.0
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
75
598
1.27
1.16
1.1
1.1
u/ml
9.6
8.2
0.19
41
369
(3031040) Bacteria [#/volume] in Urine by Automated count
823
7844
1.10
1.16
4.8
3.7
e6/l
420.4
493.8
0.09
21
74
(3048929) Epstein Barr virus Ab [Presence] in Serum
134
1137
1.19
1.16
1.5
1.4
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
5
20
2.50
1.15
1.0
1.6
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
1266
12344
1.13
1.15
4.0
3.9
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1305
12749
1.14
1.15
9.1
7.8
u/l
25.5
25.6
0.04
1264
12306
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
78
963
0.80
1.14
1.4
1.5
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
21
134
1.57
1.14
1.7
1.4
—
—
—
0
0
(3044889) 12 lead EKG panel
678
6405
1.10
1.14
2.6
2.5
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
103
854
1.22
1.13
3.5
3.4
pmol/l
4.8
4.8
0.19
90
769
(3015736) pH of Urine
497
4626
1.11
1.12
3.3
2.7
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
59
751
0.78
1.12
2.3
2.4
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
852
8144
1.10
1.12
3.3
3.0
u/l
34.1
32.4
0.46
811
7792
(3044640) Blood type and Crossmatch panel - Blood
361
3303
1.12
1.11
3.0
2.2
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
21
135
1.56
1.11
1.7
1.4
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
406
3740
1.11
1.11
1.6
1.5
g/l
2.0
1.9
0.16
255
2193
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
7
31
2.26
1.10
1.1
1.1
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
7
31
2.26
1.10
3.4
2.6
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
35
252
1.40
1.09
2.1
1.8
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
130
1108
1.19
1.08
1.4
1.3
u/ml
134.7
288.6
4.20
121
1030
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
21
136
1.55
1.08
1.7
1.4
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
118
997
1.20
1.08
1.6
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
79
967
0.81
1.08
1.4
1.5
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
7
32
2.19
1.08
1.7
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
79
966
0.81
1.07
1.4
1.5
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
48
365
1.32
1.07
1.0
1.1
u/ml
0.2
0.4
0.88
11
89
(3051387) C reactive protein [Mass/volume] in Capillary blood
33
236
1.41
1.07
3.2
2.9
mg/l
22.0
25.7
0.31
18
146
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
13
74
1.76
1.06
1.3
1.1
%
101.2
91.3
—
6
39
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
21
137
1.54
1.05
3.5
3.5
e9/l
0.2
0.2
0.57
15
114
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
7
33
2.13
1.05
1.7
1.4
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
16
253
0.63
1.05
1.9
1.8
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
12
67
1.80
1.04
1.8
4.6
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
323
2949
1.12
1.04
1.5
1.6
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
66
527
1.26
1.03
1.1
1.1
u/ml
4.4
6.1
—
6
76
(3016018) Differential panel - Cerebral spinal fluid
22
146
1.51
1.03
2.2
2.2
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
266
2402
1.13
1.03
2.6
2.2
mg/l
1.1
0.9
0.49
192
1673
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
81
663
1.23
1.03
1.3
1.2
u/ml
0.7
3.0
3.57
38
330
(3002619) Bacteria identified in Specimen by Culture
7
34
2.06
1.03
1.1
1.1
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
13
75
1.74
1.02
2.3
1.8
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
13
75
1.74
1.02
2.3
1.8
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
13
75
1.74
1.02
2.3
1.8
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
19
122
1.56
1.02
1.1
1.0
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
623
5888
1.10
1.01
5.2
4.1
estimate
0.0
0.0
0.50
146
1217
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
21
139
1.52
1.00
2.1
1.7
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
21
139
1.52
1.00
3.5
3.5
e6/l
523.4
489.8
0.11
15
113
(3025468) Yersinia sp identified in Specimen by Organism specific culture
20
131
1.53
1.00
1.8
1.4
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
627
5932
1.09
0.99
3.8
3.0
estimate
0.0
0.0
0.50
143
1188
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
19
123
1.55
0.99
1.6
1.8
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
332
3044
1.11
0.99
3.3
2.7
mmol/l
2.4
2.4
0.13
293
2742
(3025941) Bacteria identified in Stool by Culture
91
758
1.21
0.98
1.1
1.2
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
11
61
1.81
0.98
2.2
3.4
u/ml
822.1
669.8
0.29
11
61
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
32
232
1.39
0.97
1.2
1.1
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
20
132
1.52
0.97
1.8
1.4
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
17
108
1.58
0.96
1.0
1.3
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
38
501
0.75
0.96
1.7
1.5
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
1358
13336
1.13
0.95
10.3
8.3
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
24
166
1.45
0.94
11.5
7.3
u/ml
0.2
0.3
1.41
15
89
(3005988) Vibrio sp identified in Specimen by Organism specific culture
20
133
1.51
0.94
1.8
1.4
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
135
1171
1.17
0.94
1.3
1.2
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
7
37
1.90
0.94
1.3
2.0
mmol/l
7.7
9.3
—
7
31
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
6
28
2.15
0.91
1.5
1.3
u/l
15.3
12.9
—
6
28
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
219
1971
1.13
0.91
1.2
1.3
iu/ml
18.7
22.6
0.46
65
555
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
18
118
1.53
0.91
2.5
3.7
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
129
1119
1.17
0.90
3.9
3.3
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
277
2530
1.11
0.89
3.4
2.2
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
6
29
2.07
0.89
1.5
1.3
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
207
1859
1.13
0.89
1.2
1.2
u/ml
14.9
10.0
0.35
77
706
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
10
56
1.79
0.87
1.6
1.4
—
—
—
0
0
(21494434) Karyotype in Bone marrow
11
64
1.72
0.86
1.8
1.2
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
22
153
1.44
0.85
1.7
1.6
—
—
—
0
0
(3013512) EKG study
224
2028
1.12
0.85
2.8
2.6
—
—
—
0
0
(3026782) Osmolality of Urine
228
2067
1.12
0.85
3.4
2.6
mosm/kgh2o
588.7
580.8
0.19
203
1776
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
16
104
1.54
0.84
1.3
1.2
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
304
2802
1.10
0.83
1.6
1.5
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
22
154
1.43
0.83
1.1
1.2
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
11
65
1.70
0.82
1.8
1.2
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
191
1719
1.13
0.81
2.3
2.3
u/l
8022.3
6361.1
0.26
66
605
(3016650) Hepatitis A virus Ab [Presence] in Serum
32
241
1.33
0.80
1.2
1.1
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
442
4155
1.09
0.80
10.0
6.2
mmol/l
1.2
1.2
0.36
415
3836
(3005719) IgG [Mass/volume] in Serum or Plasma
114
992
1.16
0.79
3.2
3.0
g/l
10.0
10.3
0.68
106
918
(36660697) Celiac disease serology panel - Serum
179
1608
1.13
0.78
1.2
1.2
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
37
473
0.78
0.78
1.8
1.6
—
—
—
0
0
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
6
34
1.77
0.76
1.2
1.2
u/l
35.5
39.9
—
6
29
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
10
59
1.70
0.75
1.2
1.1
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
23
166
1.39
0.75
2.1
2.2
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
54
441
1.23
0.75
4.0
5.4
g/l
0.2
0.4
1.06
30
250
(4035726)
73
615
1.20
0.75
1.5
1.5
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
18
255
0.70
0.75
1.4
1.8
pmol/l
143.1
178.5
0.69
18
242
(3051651) Icteric interference index of Serum or Plasma
13
83
1.57
0.75
9.5
4.4
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
41
325
1.27
0.73
1.8
1.4
—
771.4
—
0
7
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
42
334
1.26
0.73
1.5
1.5
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
7
39
1.80
0.72
5.3
2.9
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
79
922
0.85
0.72
3.7
4.1
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
88
758
1.17
0.71
1.9
1.8
g/l
1.3
1.3
0.03
83
714
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
39
309
1.27
0.71
1.1
1.1
u/ml
3.7
2.4
0.28
14
125
(3037692) Legionella sp identified in Specimen by Organism specific culture
5
26
1.93
0.70
1.0
1.2
—
—
—
0
0
(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma
5
26
1.93
0.70
1.0
1.7
nmol/l
9.9
4.1
—
5
20
(3000570) Elastase.pancreatic [Mass/mass] in Stool
32
247
1.30
0.70
1.7
1.4
ug/g
335.0
321.6
0.15
20
117
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
15
101
1.49
0.70
1.3
1.5
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
50
607
0.82
0.70
17.8
10.3
inr
1.2
1.2
—
8
102
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
20
274
0.73
0.69
1.3
1.8
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
10
157
0.63
0.69
1.0
1.0
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
143
1280
1.13
0.68
3.7
3.4
ng/l
893.3
717.9
0.21
109
988
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
5
27
1.85
0.68
17.8
19.4
umol/l
0.3
0.4
—
5
27
(3024891) Influenza virus A+B Ag [Presence] in Specimen
38
474
0.80
0.68
1.2
1.2
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
7
42
1.67
0.68
1.3
1.2
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
496
4713
1.08
0.68
2.4
2.5
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1043
10172
1.07
0.68
9.0
7.4
ml/min/173m2
100.6
100.5
0.06
800
7658
(3026008) Bacteria identified in Urine by Culture
345
3232
1.09
0.68
3.0
2.2
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
457
4333
1.08
0.66
2.3
2.3
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
5
28
1.79
0.66
1.6
1.5
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
5
28
1.79
0.66
1.6
1.5
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
95
830
1.15
0.65
1.5
1.5
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
86
746
1.16
0.65
3.0
3.3
%
21.0
22.3
0.24
28
256
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
144
1295
1.12
0.65
2.5
2.2
mmol/l
2.4
2.4
0.21
120
1116
(3010726) Horse dander IgE Ab [Units/volume] in Serum
68
579
1.18
0.64
1.1
1.1
u/ml
1.5
3.8
1.58
22
159
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
5
29
1.73
0.64
1.2
1.7
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
148
1336
1.12
0.63
1.3
1.2
iu/ml
98.8
150.9
1.65
59
503
(3007566) Smooth muscle Ab [Titer] in Serum
40
324
1.24
0.62
1.8
1.6
titre
104.0
69.2
—
5
39
(3020876) Protein [Mass/time] in 24 hour Urine
8
50
1.60
0.61
1.4
2.2
—
1.6
—
0
8
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
51
426
1.20
0.60
3.9
4.1
ug/l
7.5
19.3
0.47
36
309
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
0
20
0.00
0.60
0.0
1.0
—
617.0
—
0
13
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
0
20
0.00
0.60
0.0
1.0
—
244.2
—
0
13
(3013293) Extractable nuclear Ab [Presence] in Serum
0
20
0.00
0.60
0.0
1.6
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
0
20
0.00
0.60
0.0
1.1
—
37.3
—
0
12
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
21
0.00
0.60
0.0
1.1
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
989
9650
1.07
0.60
2.9
2.8
mmol/l
1.2
1.2
0.50
936
9128
(3006184) Hemoglobin [Mass/volume] in Capillary blood
30
236
1.28
0.60
1.9
2.5
g/l
134.5
133.5
0.12
23
189
(3018418) pH of Serum or Plasma
272
2539
1.09
0.59
5.5
3.3
ph
7.4
7.4
0.06
58
464
(3018095) Leukocytes [#/volume] in Urine
427
4056
1.07
0.59
4.7
3.5
e6/l
71.9
76.0
0.05
279
2598
(3034092) Cytoplasmic Ig cells/100 cells in Blood
0
22
0.00
0.59
0.0
2.6
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
128
1151
1.12
0.59
1.9
1.5
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
11
72
1.53
0.59
1.4
1.8
—
—
—
0
0
(1616796) Gas panel - Central venous blood
27
210
1.29
0.58
6.7
3.5
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
23
0.00
0.58
0.0
1.1
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
545
5223
1.07
0.58
1.8
1.9
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
6
35
1.72
0.57
1.8
1.7
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
6
35
1.72
0.57
1.2
3.9
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
6
35
1.72
0.57
1.2
1.3
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
15
106
1.42
0.57
9.7
3.9
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
234
2174
1.09
0.57
4.1
2.6
e6/l
7.4
8.9
0.85
212
1899
(3014148) Varicella zoster virus Ab [Titer] in Serum
38
310
1.23
0.57
1.2
1.1
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
12
81
1.48
0.57
1.2
1.2
—
—
—
0
0
(40768443) Skin Pathology biopsy report
44
365
1.21
0.56
1.1
1.1
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
22
167
1.32
0.56
2.0
1.6
—
—
—
0
0
(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma
16
115
1.39
0.56
1.3
1.4
mu/l
597.9
438.4
0.42
16
110
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
24
307
0.78
0.55
1.3
1.2
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
6
37
1.62
0.55
1.0
1.2
—
—
—
0
0
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
6
37
1.62
0.55
1.2
1.2
u/l
296.5
90.0
—
6
31
(3014133) Dog dander IgE Ab [Units/volume] in Serum
53
450
1.18
0.54
1.1
1.1
u/ml
5.7
5.8
0.02
27
195
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
44
367
1.20
0.54
2.3
2.1
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
12
82
1.47
0.54
1.1
1.1
miu/ml
1553.5
1436.9
0.19
12
82
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
11
159
0.69
0.54
1.1
1.1
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
10
147
0.68
0.53
1.1
1.4
promille
0.5
1.3
—
10
116
(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma
16
117
1.37
0.52
1.3
1.4
%
71.8
74.4
0.31
16
112
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
9
132
0.68
0.52
1.0
1.1
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
36
296
1.22
0.51
2.2
2.4
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
6
40
1.50
0.51
3.7
4.1
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
17
126
1.35
0.51
1.3
1.5
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
106
953
1.12
0.51
4.0
3.4
ug/l
1.4
1.6
0.49
98
865
(3021901) Oxygen saturation in Capillary blood
19
144
1.32
0.50
7.7
2.9
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
9
65
1.39
0.50
1.3
1.5
—
—
—
0
0
(3008092) Baker's yeast IgG Ab [Units/volume] in Serum
6
41
1.46
0.50
1.0
1.2
—
23.1
—
0
12
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
16
118
1.36
0.50
1.2
1.4
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
116
1277
0.90
0.49
2.3
1.9
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
339
3219
1.07
0.48
4.4
3.1
e6/l
37.1
56.9
0.52
260
2395
(3014111) Lactate [Moles/volume] in Serum or Plasma
83
738
1.13
0.48
15.3
8.0
mmol/l
1.2
1.3
0.18
78
692
(3012544) pH of Venous blood
127
1158
1.10
0.48
8.9
6.3
—
7.3
—
0
6
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
21
163
1.29
0.48
1.2
1.3
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
300
2838
1.07
0.48
3.6
3.5
mmol/l
8.2
8.7
0.82
267
2539
(3039443) Prostate specific Ag panel - Serum or Plasma
13
93
1.40
0.48
1.5
1.6
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
38
452
0.84
0.48
1.9
1.6
iu/ml
0.0
0.2
—
7
82
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
56
644
0.86
0.47
1.4
1.6
mg/l
6.6
3.5
0.54
32
420
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
107
968
1.11
0.47
1.5
1.6
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
68
598
1.14
0.47
1.7
1.7
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
126
1151
1.10
0.46
1.7
1.6
mu/l
353.4
327.6
0.30
108
1033
(3024928) Oxygen saturation in Venous blood
25
200
1.25
0.46
6.2
5.3
—
—
—
0
0
(4198724)
14
187
0.75
0.45
1.3
1.7
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
353
3364
1.06
0.45
1.7
1.6
pmol/l
103.1
97.4
1.52
201
1869
(3007461) Platelets [#/volume] in Blood
1469
14581
1.11
0.45
16.9
13.9
e9/l
261.9
263.9
0.65
1435
14150
(44813793)
20
156
1.29
0.45
1.1
1.0
—
—
—
0
0
(3000991) Gas panel - Venous blood
113
1030
1.10
0.44
16.8
9.0
—
—
—
0
0
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
10
69
1.45
0.44
1.8
2.6
—
216.7
—
0
10
(3052851) Hemolysis interference index of Serum or Plasma
35
293
1.20
0.44
6.6
3.2
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
18
139
1.30
0.43
1.2
1.2
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
22
175
1.26
0.43
1.4
2.7
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
22
175
1.26
0.43
1.1
1.2
—
—
—
0
0
(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
5
31
1.61
0.43
1.4
1.8
—
17.5
—
0
10
(3025130) Human papilloma virus identified in Specimen
19
240
0.79
0.42
1.6
1.7
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
5
32
1.56
0.42
1.4
1.8
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
8
57
1.40
0.42
1.6
1.6
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
8
57
1.40
0.42
1.1
1.1
—
—
—
0
0
(3012501) Base excess in Blood by calculation
24
194
1.24
0.42
6.6
4.5
mmol/l
2.3
2.1
0.17
13
109
(3020874) Milk IgE Ab [Units/volume] in Serum
23
185
1.25
0.42
1.2
1.1
u/ml
1.9
2.7
—
8
82
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
179
1673
1.08
0.41
3.2
2.8
e6/l
4.9
4.5
0.13
93
849
(40768806) Pleura Pathology biopsy report
5
33
1.52
0.41
1.2
1.6
—
—
—
0
0
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
2.4
—
3.3
—
0
6
(3051593) INR in Capillary blood by Coagulation assay
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
267
2532
1.07
0.41
2.1
2.0
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
27
222
1.22
0.41
1.2
1.1
—
—
—
0
0
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
0
17
0.00
0.40
0.0
1.8
—
1397.5
—
0
8
(44816559) Phosphatidylethanol [Mass/volume] in Blood
32
379
0.84
0.40
1.2
1.2
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
83
749
1.11
0.40
1.2
1.2
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
72
802
0.89
0.40
2.0
2.0
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(4281824)
8
61
1.31
0.39
1.1
1.1
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
8
61
1.31
0.39
1.5
1.2
—
—
—
0
0
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
5
35
1.43
0.39
3.0
2.5
umol/l
29.6
33.9
—
5
25
(3016273) Islet cell 512 Ab [Units/volume] in Serum
5
35
1.43
0.39
1.0
1.1
—
—
—
0
0
(4062490)
12
159
0.75
0.38
1.4
1.4
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
9
66
1.37
0.38
1.1
1.7
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
5
36
1.39
0.38
1.4
1.7
—
—
—
0
0
(3011648) Oxygen content in Venous blood
12
89
1.35
0.38
8.8
8.1
%
11.8
11.8
0.02
12
89
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
282
2688
1.06
0.37
2.6
2.5
ng/l
18.9
33.7
1.00
112
1079
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
242
2296
1.06
0.37
2.3
2.1
u/l
195.4
213.6
0.13
235
2187
(3019309) Folate [Moles/volume] in Red Blood Cells
125
1157
1.09
0.37
1.6
1.6
nmol/l
1106.2
1106.2
0.00
104
901
(3021879) Hepatitis B virus core Ab [Presence] in Serum
154
1438
1.08
0.37
1.6
1.5
—
—
—
0
0
(4024509)
9
69
1.31
0.37
1.2
1.3
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
5
37
1.35
0.37
1.4
1.7
—
—
—
0
0
(3024731) MCV [Entitic volume]
1469
14596
1.10
0.37
16.8
13.8
fl
88.9
88.7
0.56
1450
14385
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
67
601
1.12
0.37
2.4
2.2
ml/min/173m2
82.4
83.5
0.08
21
208
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
369
3834
0.95
0.36
3.9
3.2
u/l
31.8
29.7
0.47
353
3653
(3029634) Reagin Ab [Titer] in Serum by VDRL
38
328
1.16
0.36
1.5
1.7
—
4.4
—
0
5
(3021960) Folate [Moles/volume] in Serum or Plasma
200
1889
1.07
0.36
1.6
1.4
nmol/l
20.9
19.8
0.51
180
1670
(3035941) MCH [Entitic mass]
1469
14598
1.09
0.36
16.8
13.8
pg
29.8
29.7
1.19
1450
14388
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
5
77
0.65
0.35
1.0
1.5
nmol/l
1.4
1.4
—
5
70
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
5
77
0.65
0.35
1.0
1.1
iu/ml
132.7
218.6
—
5
77
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
5
80
0.62
0.35
1.0
1.1
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
9
125
0.72
0.35
1.0
1.2
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
1470
14611
1.09
0.34
17.0
13.9
g/l
134.9
135.4
0.88
1452
14404
(3010813) Leukocytes [#/volume] in Blood
1470
14611
1.09
0.34
16.9
13.9
e9/l
6.6
6.7
1.48
1431
14155
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
10
73
1.37
0.34
1.4
2.6
ug/l
33.4
24.5
—
10
63
(3026361) Erythrocytes [#/volume] in Blood
1469
14601
1.09
0.34
16.8
13.8
e12/l
4.5
4.6
1.67
1431
14152
(3045462) Protein/Creatinine [Ratio] in Urine
12
91
1.32
0.33
3.9
7.0
g/mol
28.5
79.4
1.06
12
78
(43055514) Macroprolactin [Presence] in Serum or Plasma
12
91
1.32
0.33
1.3
1.3
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
15
118
1.27
0.33
1.5
1.8
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
15
118
1.27
0.33
1.3
1.2
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
63
568
1.11
0.33
1.4
1.3
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
6
90
0.67
0.32
1.0
1.3
ug/l
3.4
5.4
—
6
80
(44790049)
19
155
1.23
0.32
1.7
1.6
—
—
—
0
0
(44790048)
19
155
1.23
0.32
1.7
1.6
—
—
—
0
0
(44790047)
19
155
1.23
0.32
1.7
1.6
—
—
—
0
0
(44806118)
19
155
1.23
0.32
1.7
1.6
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
26
220
1.18
0.31
1.1
1.1
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
15
119
1.26
0.31
1.3
1.2
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
15
119
1.26
0.31
1.4
1.1
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
142
1333
1.07
0.31
1.9
1.5
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
407
3938
1.04
0.31
1.9
1.7
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
25
211
1.19
0.31
1.1
1.1
%
112.7
115.3
0.19
25
189
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
7
52
1.35
0.31
9.0
7.0
—
—
—
0
0
(3000492) Spirometry study
124
1160
1.07
0.30
1.4
1.3
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
64
581
1.11
0.30
1.3
1.4
—
—
—
0
0
(3034426) Prothrombin time (PT)
7
54
1.30
0.30
1.0
1.3
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
10
75
1.33
0.30
3.3
3.1
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
7
55
1.27
0.30
1.0
1.1
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
97
900
1.08
0.29
1.7
1.7
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
124
1321
0.93
0.29
1.7
1.9
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
19
157
1.21
0.29
1.3
1.4
—
—
—
0
0
(3020891) Body temperature
20
238
0.84
0.29
4.8
5.2
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
20
167
1.20
0.28
2.9
3.2
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
34
298
1.14
0.28
1.2
1.2
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
14
112
1.25
0.28
2.1
1.6
u/ml
2.1
0.5
—
5
38
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1026
10125
1.04
0.28
3.1
2.9
mmol/l
5.4
5.5
3.90
960
9417
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
53
479
1.11
0.28
1.6
1.6
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
180
1712
1.06
0.28
3.1
2.7
e6/l
1.1
1.1
0.08
94
889
(3015183) Erythrocyte sedimentation rate
12
94
1.28
0.28
1.1
1.2
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1033
10197
1.04
0.27
3.4
3.2
mmol/l
2.7
2.8
1.97
974
9596
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
138
1460
0.94
0.27
1.9
2.1
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
49
542
0.90
0.27
1.4
1.5
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
17
204
0.83
0.27
3.8
5.4
umol/l
395.1
380.9
0.19
17
178
(3004588) Protein electrophoresis panel - Serum or Plasma
33
290
1.14
0.27
1.5
1.8
—
—
—
0
0
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
8
66
1.21
0.26
2.0
1.8
—
875521.4
—
0
7
(4306422)
25
215
1.16
0.26
1.2
1.2
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
13
104
1.25
0.26
1.5
1.1
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
12
95
1.26
0.26
1.1
1.2
—
—
—
0
0
(3019225) pH of Specimen
79
732
1.08
0.26
6.4
3.7
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
5
74
0.67
0.26
1.6
1.1
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
122
1150
1.07
0.26
1.9
2.3
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
61
559
1.09
0.25
1.3
1.2
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
121
1142
1.06
0.25
9.2
6.3
mmol/l
1.7
1.5
0.39
102
920
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
373
3623
1.04
0.25
4.5
3.2
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
247
2379
1.04
0.24
1.7
1.6
mmol/l
1.3
1.3
0.48
230
2111
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
17
142
1.20
0.24
1.2
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
17
142
1.20
0.24
1.2
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
17
142
1.20
0.24
1.2
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
17
142
1.20
0.24
1.2
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
17
142
1.20
0.24
1.2
1.2
—
—
—
0
0
(4094501)
13
158
0.82
0.23
1.1
1.1
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
38
1.32
0.23
1.4
1.7
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
17
143
1.19
0.23
1.2
1.2
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
27
237
1.14
0.23
1.7
1.6
—
—
—
0
0
(40768793) Breast Pathology biopsy report
24
209
1.15
0.22
1.0
1.2
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
5
40
1.25
0.22
1.8
1.1
—
32.0
—
0
5
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
5
40
1.25
0.22
1.8
1.1
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
60
554
1.09
0.22
2.3
2.4
ug/l
0.7
0.7
0.02
32
283
(3022313) Gas panel - Capillary blood
76
709
1.08
0.22
7.4
5.0
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
37
333
1.11
0.22
2.1
1.9
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
10
79
1.27
0.22
1.3
1.7
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
20
231
0.86
0.22
1.5
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
20
231
0.86
0.22
1.5
1.3
—
—
—
0
0
(3007916) DNA double strand Ab [Titer] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3020123) Porphyrins [Interpretation] in Serum or Plasma
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.3
—
17.0
—
0
10
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3051339) Copper [Moles/volume] in Blood
0
12
0.00
0.21
0.0
1.3
—
15.3
—
0
12
(3037556) Urate [Mass/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
348
3571
0.97
0.21
1.8
1.8
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
5
43
1.16
0.21
1.0
1.1
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
11
134
0.82
0.20
1.4
1.3
—
—
—
0
0
(1002224) Polysomnography panel
48
441
1.09
0.20
1.0
1.1
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
0
14
0.00
0.20
0.0
1.7
—
—
—
0
0
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
0
14
0.00
0.20
0.0
1.1
—
56.3
—
0
7
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
191
1980
0.96
0.20
1.5
1.5
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
184
1772
1.04
0.19
4.6
4.3
mg/mmol
8.1
11.3
0.62
129
1247
(46235355) HIV 1 and 2 tests - Meaningful Use set
529
5191
1.03
0.19
2.2
2.1
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
19
165
1.15
0.19
2.6
2.8
%
17.3
17.4
0.03
12
87
(3021788) Differential panel - Synovial fluid
14
118
1.19
0.19
1.9
1.8
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
16
137
1.17
0.18
1.4
1.4
—
—
—
0
0
(4268621)
20
175
1.14
0.18
2.0
2.4
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
177
1708
1.04
0.18
3.9
3.6
mg/l
421.4
261.8
0.18
125
1208
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
7
61
1.15
0.17
1.6
1.9
—
—
—
0
0
(4211845)
7
61
1.15
0.17
1.9
2.2
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
7
62
1.13
0.17
1.9
2.2
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
7
62
1.13
0.17
1.0
1.1
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
13
110
1.18
0.17
1.2
1.4
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
307
2996
1.03
0.17
3.9
3.0
—
—
—
0
0
(3003338) MCHC [Mass/volume]
1195
12023
0.97
0.17
13.9
11.7
g/l
334.6
333.7
2.63
1184
11906
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
129
1238
1.05
0.17
1.1
1.1
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
19
215
0.88
0.17
1.5
1.5
mmol/l
5.7
6.8
1.78
14
146
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
8
69
1.16
0.16
1.8
1.4
%
—
83.9
—
0
7
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
14
120
1.17
0.16
1.1
1.3
—
32.4
—
0
5
(3016879) Cocaine [Presence] in Urine
148
1533
0.96
0.16
1.7
1.9
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
303
2960
1.03
0.16
4.0
3.0
e6/l
0.2
0.3
1.21
229
2161
(3009542) Hematocrit [Volume Fraction] of Blood
1293
12858
1.03
0.16
12.8
10.4
%
40.0
40.2
0.39
1075
10874
(40768441) Liver Pathology biopsy report
10
83
1.21
0.15
1.9
1.7
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
35
379
0.92
0.15
1.2
1.1
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
9
81
1.11
0.15
5.1
6.8
—
—
—
0
0
(3008898) HLA-B27 [Presence]
69
727
0.95
0.15
1.1
1.1
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
13
150
0.87
0.14
2.1
2.5
ug/min
22.7
131.9
—
6
100
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
25
275
0.91
0.14
1.4
1.6
—
1508.6
—
0
7
(3042936) Bacteria identified in Isolate by Culture
129
1244
1.04
0.14
2.2
1.8
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
36
333
1.08
0.14
1.2
1.1
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
16
141
1.14
0.13
2.6
1.7
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
11
128
0.86
0.13
7.9
11.0
mmol/l
0.6
0.6
0.17
11
121
(3022621) pH of Urine by Test strip
73
696
1.05
0.13
2.4
2.3
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
11
94
1.17
0.13
1.2
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
11
94
1.17
0.13
1.2
1.0
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
38
355
1.07
0.12
1.2
1.1
—
11.7
—
0
25
(3001019) Free T4 and TSH panel - Serum or Plasma
94
904
1.04
0.12
1.6
1.6
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
26
239
1.09
0.12
1.2
1.4
u/ml
1.6
5.1
—
10
113
(3049717) Cytology report of Urine Cyto stain
15
133
1.13
0.12
1.7
2.1
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
159
1632
0.97
0.11
1.7
1.8
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
213
2083
1.03
0.11
1.5
1.6
%
1.3
1.4
0.33
193
1900
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
35
373
0.94
0.11
1.2
1.1
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
15
134
1.12
0.10
1.0
1.6
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
10
115
0.87
0.10
3.5
2.0
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
13
146
0.89
0.10
1.3
1.7
g/l
0.2
0.5
0.58
13
141
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
26
241
1.08
0.10
1.2
1.3
u/ml
1.3
6.2
—
7
94
(42529406) Shigella sp [Presence] in Stool by Culture
36
382
0.94
0.10
1.2
1.1
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
5
45
1.11
0.09
1.4
1.9
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
16
176
0.91
0.09
1.4
1.5
—
11.4
—
0
21
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1024
10183
1.02
0.09
3.3
3.1
mmol/l
4.6
4.6
0.48
971
9664
(3045424) Erythrocytes [Presence] in Urine
19
174
1.09
0.09
1.7
1.3
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
163
1665
0.98
0.09
1.7
1.9
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
89
862
1.03
0.09
1.3
1.3
miu/ml
223.1
231.3
0.08
40
434
(40758558) Short blood count panel - Blood
318
3135
1.02
0.09
8.2
7.0
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
22
237
0.93
0.09
1.1
1.1
iu/ml
96.6
199.3
—
8
78
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
6
54
1.11
0.09
4.0
5.2
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
6
54
1.11
0.09
2.0
2.6
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
55
528
1.04
0.08
1.6
2.0
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
32
302
1.06
0.08
1.2
1.1
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
5
60
0.83
0.08
1.0
1.0
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
100
973
1.03
0.08
1.3
1.3
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
6
72
0.83
0.07
8.5
3.5
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
163
1660
0.98
0.07
1.7
1.8
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
264
2675
0.98
0.07
2.9
2.9
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
125
1277
0.98
0.07
1.5
1.4
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
8
75
1.07
0.07
1.1
1.2
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
68
701
0.97
0.07
6.6
4.9
mmol/l
23.9
24.4
1.10
68
689
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
9
85
1.06
0.07
1.0
1.2
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
45
468
0.96
0.07
4.4
2.9
umol/l
5.4
6.0
0.20
37
367
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
62
600
1.03
0.07
1.3
1.3
—
—
—
0
0
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
14
128
1.09
0.06
1.3
1.3
—
296.0
—
0
5
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
167
1643
1.02
0.06
1.6
1.5
pmol/l
461.2
25467551.8
1.59
136
1445
(3002523) Influenza virus A Ag [Presence] in Specimen
35
365
0.96
0.06
1.3
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
35
365
0.96
0.06
1.3
1.1
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
32
306
1.05
0.05
2.3
2.3
e6/l
9.1
11.4
0.18
25
235
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
40
415
0.96
0.05
1.5
2.1
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
38
366
1.04
0.05
1.2
1.2
u/ml
7.0
48.8
—
6
19
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
32
307
1.04
0.05
2.3
2.3
e6/l
704.4
165.8
0.59
25
247
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
41
423
0.97
0.04
1.9
2.0
ug/l
9.0
6.6
0.44
36
365
(3000764) Benzodiazepines [Presence] in Urine
163
1649
0.99
0.04
1.7
1.9
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
15
141
1.06
0.03
1.4
2.1
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
15
141
1.06
0.03
2.2
2.1
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1012
10095
1.01
0.03
3.2
3.0
mmol/l
1.5
1.5
0.07
956
9545
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
26
251
1.04
0.02
1.4
1.5
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
40
409
0.98
0.02
4.8
2.4
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
26
252
1.03
0.02
1.1
1.1
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
89
880
1.01
0.02
7.3
4.7
mmol/l
1.3
1.1
0.30
62
623
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
137
1359
1.01
0.02
1.5
1.4
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
94
930
1.01
0.01
2.7
2.8
%
34.1
32.5
0.60
72
692
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
12
113
1.06
0.01
1.1
1.3
nmol/l
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
17
177
0.96
0.01
1.2
1.1
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
50
492
1.02
0.01
1.2
1.2
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
101
1018
0.99
0.01
2.6
2.2
u/l
32.1
32.1
0.00
83
859
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
35
357
0.98
0.01
2.5
1.9
iu/l
3.0
5.2
1.15
15
141
(3023420) DNA double strand Ab [Units/volume] in Serum
15
144
1.04
0.00
1.6
1.5
—
17.0
—
0
6
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
33
336
0.98
0.00
1.2
1.2
u/ml
4.4
10.4
—
5
54
(40761535) Cells panel - Urine sediment
66
666
0.99
0.00
3.0
3.1
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
124
1234
1.00
0.00
1.5
1.3
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
10
97
1.03
0.00
1.2
1.0
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
12
116
1.03
0.00
2.0
2.6
mmol/l
68.3
76.2
0.17
12
105
(3044941) Cell count panel - Synovial fluid
10
103
0.97
0.00
2.2
1.4
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
13
135
0.96
0.00
1.0
1.3
nmol/l
0.4
0.5
0.63
13
128
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
15
154
0.97
0.00
1.7
1.4
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
42
419
1.00
0.00
1.2
1.3
—
—
—
0
0
(3009343) pH of Capillary blood
89
893
1.00
0.00
7.3
4.7
ph
7.4
7.4
0.46
12
73
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
11
112
0.98
0.00
1.5
1.4
umol/l
8.7
10.2
1.09
11
107
(3045683) HLA typing for celiac disease panel - Blood or Tissue
12
125
0.96
0.00
1.0
1.0
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
16
163
0.98
0.00
1.3
1.5
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
16
163
0.98
0.00
1.3
1.5
g/l
3.6
3.7
0.10
11
133
(3014599) Egg white IgE Ab [Units/volume] in Serum
18
182
0.99
0.00
1.0
1.1
u/ml
0.3
14.0
—
5
69
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
10
101
0.99
0.00
1.4
1.2
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
11
114
0.96
0.00
1.4
1.2
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
11
114
0.96
0.00
1.0
1.1
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
306
3056
1.00
0.00
2.4
2.1
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
28
284
0.99
0.00
1.5
1.7
mmol/l
6.6
7.3
1.35
17
170
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
20
197
1.02
0.00
1.3
1.2
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
25
245
1.02
0.00
1.5
2.2
mg/l
8.9
9.4
0.17
25
230
(3033658) Prothrombin time (PT) actual/Normal
268
2675
1.00
0.00
6.3
4.3
%
90.8
93.5
1.36
261
2597
(1761482) Bacteria [#/volume] in Urine by Culture
16
161
0.99
0.00
8.4
2.7
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
60
595
1.01
0.00
1.4
1.3
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
10
96
1.04
0.00
1.0
1.1
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
10
105
0.95
0.00
2.4
1.9
umol/l
12.0
22.3
—
10
99
(3035933) Granulocytes/100 leukocytes in Blood
10
102
0.98
0.00
1.1
2.2
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
0
9
0.00
0.00
0.0
7.4
—
—
—
0
0
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
0
6
0.00
0.00
0.0
1.5
—
3.0
—
0
6
(3018834) Bilirubin.total [Presence] in Urine by Test strip
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
0
6
0.00
0.00
0.0
6.7
—
—
—
0
0
(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3027974) Hepatitis B virus e Ag [Presence] in Serum
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3029612) Listeria sp Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3022475) Manganese [Moles/volume] in Blood
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine
0
5
0.00
0.00
0.0
1.0
—
250.0
—
0
5
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
7
72
0.97
0.00
1.6
1.5
g/l
0.8
1.0
—
7
72
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
5
50
1.00
0.00
1.4
1.2
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
5
52
0.96
0.00
1.8
1.3
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
7
77
0.91
0.00
2.1
1.1
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036603) Volume of Urine
5
58
0.86
0.00
1.2
1.5
—
2237.6
—
0
7
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3025315) Body weight
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
5
54
0.93
0.00
1.2
1.2
—
—
—
0
0
(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine
0
8
0.00
0.00
0.0
1.0
—
428.9
—
0
8
(3013762) Body weight Measured
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3009677) Dengue virus Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
5
57
0.88
0.00
1.0
1.4
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
8
80
1.00
0.00
1.0
1.2
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
6
62
0.97
0.00
1.0
1.2
—
3.7
—
0
6
(3012920) Ethanol [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.8
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
5
56
0.89
0.00
2.0
2.2
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
8
80
1.00
0.00
1.1
1.2
—
—
—
0
0
(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
4.8
—
0.2
—
0
5
(3040893) Potassium [Moles/volume] in Capillary blood
0
8
0.00
0.00
0.0
1.5
—
4.2
—
0
8
(3003157) Bacteria [#/volume] in Mother's milk
0
7
0.00
0.00
0.0
9.9
—
—
—
0
0
(3045519) Venlafaxine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
294.8
—
0
5
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
9
94
0.96
0.00
1.7
1.6
—
—
—
0
0
(3002481) Calcium/Creatinine [Mass Ratio] in Urine
0
5
0.00
0.00
0.0
4.4
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
6
61
0.98
0.00
1.2
1.2
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3016135) IgD [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
35.2
—
0
5
(3007919) Fasciola sp Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.0
—
16.4
—
0
7
(3021691) Plasmodium malariae Ab [Titer] in Serum
0
5
0.00
0.00
0.0
2.8
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
7
74
0.95
0.00
1.0
1.0
—
—
—
0
0
(3036180) Methadone [Presence] in Urine
0
7
0.00
0.00
0.0
2.9
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
6
66
0.91
0.00
2.5
1.7
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
0
8
0.00
0.00
0.0
2.1
—
2278.0
—
0
8
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint K11_HYPO_ONLY and mortality.

Females

Parameter HR [95% CI] p-value
K11_HYPO_ONLY 1.193 [0.89, 1.61] 0.245
Birth year 0.992 [0.98, 1.0] 0.07

During the follow-up period (1.1.1998 — 31.12.2019), 65 out of 17984 females with K11_HYPO_ONLY died.

Males

Parameter HR [95% CI] p-value
K11_HYPO_ONLY 0.962 [0.71, 1.31] 0.805
Birth year 0.989 [0.98, 1.0] 0.029

During the follow-up period (1.1.1998 — 31.12.2019), 57 out of 12761 males with K11_HYPO_ONLY died.

Mortality risk

Mortality risk for people of age

years, who have K11_HYPO_ONLY.

N-year risk Females Males
1 0.111% 0.2%
5 0.683% 1.062%
10 1.67% 2.862%
15 2.925% 5.365%
20 5.103% 9.419%

Relationships between endpoints

↥

Index endpoint: K11_HYPO_ONLY – Tooth agenesis EXCLUDE clefts and syndromes

GWS hits: 12

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data